Delaware’s opioid abatement funding distribution process could resume in March after being on hold for seven months amid fraud concerns.
After opioid settlement recipient Code Purple was flagged for misusing grant funds in June, the Prescription Opioid Settlement Distribution Commission (POSDC) decided to halt all funding disbursment until grant distribution procedures could be reviewed.
POSDC oversees the distribution of funds through Delaware’s Opioid Abatement and Remediation Grant Program, which focuses on funding overdose reversal medication, supporting those in addiction treatment, funding media campaigns to prevent opioid misuse and treating opioid disorders…